Pharmaceutical News

RSS

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Researchers from LSTM Cochrane Infectious Diseases Group publish two systematic reviews this week about the safety of mefloquine (Lariam) for preventing malaria in travelers.

30 Oct 2017

Sanford Health to evaluate effectiveness of non-opioid medications

Sanford Health is one of three sites in the U.S. to launch a study to determine if non-opioid medications are as effective in managing pain after carpal-tunnel surgery.

30 Oct 2017

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Less than half of patients received their insurer's approval for prescriptions of PCSK9 inhibitors, according to new research in the American Heart Association's journal Circulation.

30 Oct 2017

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for SPINRAZA (nusinersen). The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health. The award was presented at a ceremony in New York City on October 26, 2017.

30 Oct 2017

Ameritox applauds President Trump’s declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

30 Oct 2017

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).

30 Oct 2017

Experts issue new report with recommendations aimed at stemming opioid epidemic

A group of experts, led by researchers at the Johns Hopkins Bloomberg School of Public Health in collaboration with the Clinton Foundation, today issued a new report with comprehensive recommendations aimed at stemming the opioid epidemic, a spiraling crisis that kills on average 90 people a day in the U.S., and shows few signs of reversing.

28 Oct 2017

Multiple methods found to minimize pain caused by surgery and reduce use of opioids

Studies suggest that using more than one type of pain medicine to target different pain pathways has been shown to decrease pain while reducing side effects of knee replacement surgery.

28 Oct 2017

University of Colorado’s second shingles vaccine approved by FDA

The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.

28 Oct 2017

Newly patented formulation based on nanotechnology will offer neuropathic pain relief

The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.

28 Oct 2017

Prescribed medications linked to dry mouth symptoms in older adults

For older adults, dry mouth can be a common side effect of prescribed medications. Having dry mouth means you don't have enough saliva, or spit, to keep your mouth wet. The condition can lead to problems chewing, eating, swallowing, and even talking. What's more, dry mouth puts you at higher risk for tooth decay and oral infections.

27 Oct 2017

New study investigates extent of opioid dependence and overdose in postoperative patients

Drug overdose was the leading cause of accidental death in the U.S. in 2015. Although pain management after surgery continues to rely on opioids, there are concerns that ubiquitous use of opioids has led to a growing epidemic of addiction, dependence, and overdose (ODO).

27 Oct 2017

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

In a study that could provide a roadmap for combatting the rising threat of drug-resistant pathogens, researchers have discovered the specific mechanism the body's T cells use to kill bacteria.

27 Oct 2017

CDC recommends new vaccine for shingles

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix.

25 Oct 2017

Researchers use machine learning to identify illegal selling of opioids on Twitter

Using advanced machine learning, a cross disciplinary team of University of California San Diego researchers developed technology that mined Twitter to identify entities illegally selling prescription opioids online.

25 Oct 2017

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

A new class of drugs for blood cancers such as leukemia and multiple myeloma is showing promise. But it is hobbled by a problem that also plagues other cancer drugs: targeted cells can develop resistance.

25 Oct 2017

Study reveals why Alzheimer's drugs fail in clinical trials

A tremendous amount of Amyloid-β peptide (Aβ) (a peptide of ～40 amino acids) accumulates in the brain of Alzheimer's disease patients. γ-Secretase inhibitors were designed to inhibit the enzymatic activity that produces Aβ. By reducing Aβ production, γ-secretase inhibitors were considered able to treat Alzheimer's disease (Aβ hypothesis).

25 Oct 2017

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

As the brain has limited capability for self-repair or regeneration, stem cells may represent the best therapeutic approach for counteracting damage to or degeneration of brain tissue caused by injury, aging, or disease.

24 Oct 2017

Increasing the dosage of antidepressants does not carry benefits, analysis reveals

In the current issue of Psychotherapy and Psychosomatics a new analysis discloses that increasing the dosage of antidepressant drugs does not carry benefits. As many patients with unipolar depression do not respond sufficiently to initial antidepressant monotherapy, a dose increase of the current administered antidepressant (dose escalation, high-dose treatment) is frequently carried out as next treatment measure.

24 Oct 2017

New analysis reveals insights into long-term effects of antidepressant drugs

In the current issue of Psychotherapy and Psychosomatics a new analysis discloses insights into the long term effects of antidepressant drugs. Major depressive disorder (MDD) is more often chronic or recurrent in clinical than in community samples.

24 Oct 2017

Pharmaceutical News

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Sanford Health to evaluate effectiveness of non-opioid medications

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Ameritox applauds President Trump’s declaration of opioid crisis as national public health emergency

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Experts issue new report with recommendations aimed at stemming opioid epidemic

Multiple methods found to minimize pain caused by surgery and reduce use of opioids

University of Colorado’s second shingles vaccine approved by FDA

Newly patented formulation based on nanotechnology will offer neuropathic pain relief

Prescribed medications linked to dry mouth symptoms in older adults

New study investigates extent of opioid dependence and overdose in postoperative patients

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

CDC recommends new vaccine for shingles

Researchers use machine learning to identify illegal selling of opioids on Twitter

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Study reveals why Alzheimer's drugs fail in clinical trials

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

Increasing the dosage of antidepressants does not carry benefits, analysis reveals

New analysis reveals insights into long-term effects of antidepressant drugs

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News